Viking Therapeutics
VKTX
VKTX
184 hedge funds and large institutions have $1.11B invested in Viking Therapeutics in 2023 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
43% more funds holding
Funds holding: 129 → 184 (+55)
40.25% more ownership
Funds ownership: 44.5% → 84.75% (+40%)
4% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 46
Holders
184
Holding in Top 10
4
Calls
$83.9M
Puts
$25.5M
Top Buyers
| 1 | +$182M | |
| 2 | +$83.8M | |
| 3 | +$32.6M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$28.4M |
| 5 |
DM
Deerfield Management
New York
|
+$18.7M |
Top Sellers
| 1 | -$9.48M | |
| 2 | -$9.07M | |
| 3 | -$8.25M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$6.26M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$5.73M |